MEDPAL AI is trading 5.11% down now at £6.03, amid continued volatility following sharp gains earlier in September.

  • No new company-specific announcement was identified for September 14, 2026.
  • The latest RNS was a September 11 warrant exercise; September 9 brought a board change and option issuance.
  • The broader overnight tone is risk-off, but there is insufficient evidence to attribute the decline directly to macro conditions.